InvestorsHub Logo
Post# of 253533
Next 10
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

Re: mcbio post# 149701

Sunday, 09/30/2012 11:19:45 PM

Sunday, September 30, 2012 11:19:45 PM

Post# of 253533
The MOS for the erlotinib control arm is assumed to be 7 months. So unless they have sicker patients in the trial the alternative has to be bearish if the interim is much earlier than expected.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.